<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02475590</url>
  </required_header>
  <id_info>
    <org_study_id>2008-A01590-55</org_study_id>
    <nct_id>NCT02475590</nct_id>
  </id_info>
  <brief_title>Laparoscopic Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass</brief_title>
  <official_title>Laparoscopic Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass for Morbidly Obese Patients: a Prospective Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IHU Strasbourg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>IRCAD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>IHU Strasbourg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective randomized clinical trial aiming to compare laparoscopic Roux-en-Y gastric bypass
      (RYGB) and sleeve gastrectomy (SG) with primary outcome on excess weight loss, and secondary
      outcomes on nutritional status, glycolipid profile, quality of life and pain assessments.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      No consensus is proposed by the Medical and Surgical societies to define and / or prioritize
      surgical procedures in obesity surgery. Indications are based on patient's age, sex, dietary
      habits, the importance of overweight and associated comorbidities and even if rarely
      admitted, based on knowledge of surgical teams and the cost of interventions. Given the
      decrease of gastric banding procedures, Roux-en-Y gastro-jejunal bypass is often considered
      the reference procedure.

      The gastric bypass, developed in the 60s, is performed laparoscopically since the early 90s.
      It allows for a 60% to 70% excess weight loss with control over 75% of comorbidities. It is
      recommended to follow these patients long-term because late complications can occur. These
      patients require ongoing information and regular monitoring. They must also have a
      hyper-protein diet and a vitamin substitute long-term (multivitamins, vitamin B12, calcium
      ...).

      The Sleeve gastrectomy (SG) arises as an alternative to RYGB. It was classically proposed to
      patients with a BMI greater than 60 and significant comorbidities since the procedure let to
      a significant weight reduction in patients for whom any other procedure was too difficult to
      perform. The quality of the weight loss achieved in these patients has led many teams to
      analyze the results of this intervention without conducting an additional procedure. It
      appears from the literature that even performed alone, SG presents many benefits.

      To clarify the role of sleeve gastrectomy in the bariatric procedures range, the
      investigators propose to conduct a prospective randomized study to compare laparoscopic
      sleeve gastrectomy to Roux-en-Y gastric bypass.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 2009</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Excess weight loss at 3 years</measure>
    <time_frame>At 36 months</time_frame>
    <description>% of excess weight loss</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in excess weight loss</measure>
    <time_frame>At 1, 3, 6, 12, months and every year for 10 years</time_frame>
    <description>% of excess weight loss</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nutritional status and vitamin deficiency</measure>
    <time_frame>At 1, 3, 6, 12, 18, 24, 30 and 36 months</time_frame>
    <description>Albumin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status and vitamin deficiency</measure>
    <time_frame>At 1, 3, 6, 12, 18, 24, 30 and 36 months</time_frame>
    <description>Pre-albumin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status and vitamin deficiency</measure>
    <time_frame>At 1, 3, 6, 12, 18, 24, 30 and 36 months</time_frame>
    <description>Vitamin A</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status and vitamin deficiency</measure>
    <time_frame>At 1, 3, 6, 12, 18, 24, 30 and 36 months</time_frame>
    <description>Vitamin D</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status and vitamin deficiency</measure>
    <time_frame>At 1, 3, 6, 12, 18, 24, 30 and 36 months</time_frame>
    <description>Vitamin B9</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status and vitamin deficiency</measure>
    <time_frame>At 1, 3, 6, 12, 18, 24, 30 and 36 months</time_frame>
    <description>Vitamin B12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycolipid profile</measure>
    <time_frame>At 1, 3, 6, 12, 18, 24, 30 and 36 months</time_frame>
    <description>Fasting plasma glucose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycolipid profile</measure>
    <time_frame>At 1, 3, 6, 12, 18, 24, 30 and 36 months</time_frame>
    <description>Serum insulin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycolipid profile</measure>
    <time_frame>At 1, 3, 6, 12, 18, 24, 30 and 36 months</time_frame>
    <description>HbA1c</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycolipid profile</measure>
    <time_frame>At 1, 3, 6, 12, 18, 24, 30 and 36 months</time_frame>
    <description>Triglycerides</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycolipid profile</measure>
    <time_frame>At 1, 3, 6, 12, 18, 24, 30 and 36 months</time_frame>
    <description>Cholesterol (total, HDL, LDL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life (Moorehead-Ardelt II, Gastro-intestinal Quality of Life Index (GIQLI))</measure>
    <time_frame>At 1, 3, 6, 12, 18, 24, 30 and 36 months</time_frame>
    <description>Moorehead-Ardelt II, Gastro-intestinal Quality of Life Index (GIQLI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain (visual analog scale)</measure>
    <time_frame>At 1, 3, 6, 12, 18, 24, 30 and 36 months</time_frame>
    <description>Pain assessment (visual analog scale)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Morbid Obesity</condition>
  <arm_group>
    <arm_group_label>Sleeve gastrectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laparoscopic sleeve gastrectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Roux-en-Y gastric bypass</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laparoscopic Roux-en-Y gastric bypass</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic sleeve gastrectomy</intervention_name>
    <description>Laparoscopic sleeve gastrectomy</description>
    <arm_group_label>Sleeve gastrectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic Roux-en-Y gastric bypass</intervention_name>
    <description>Laparoscopic Roux-en-Y gastric bypass</description>
    <arm_group_label>Roux-en-Y gastric bypass</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &gt;40 and &lt; 60 kg/m2

          -  No contraindication to any of the procedures

          -  No contraindication to general anesthesia

          -  No known addiction

          -  Patient able to provide informed consent

        Exclusion Criteria:

          -  Contraindication to general anesthesia

          -  Known psychiatric pathology

          -  Pregnancy

          -  Previous major digestive surgery

          -  Immunosuppressive treatment including corticoids

          -  Coagulopathy (INR&gt;1.5) or platelets &lt; 50 000/Âµl

          -  Anemia (Hb&lt;10g/dl)

          -  Severe comorbidity

          -  Malabsorptive disease or gastro-intestinal disease

          -  Myocardial infarction in previous year, angina, cardiac failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacques Marescaux, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Strasbourg university hospital, IRCAD, IHU Strasbourg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service de Chirurgie Digestive et Endocrinienne</name>
      <address>
        <city>Strasbourg</city>
        <zip>67 000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Vix M, Liu KH, Diana M, D'Urso A, Mutter D, Marescaux J. Impact of Roux-en-Y gastric bypass versus sleeve gastrectomy on vitamin D metabolism: short-term results from a prospective randomized clinical trial. Surg Endosc. 2014 Mar;28(3):821-6. doi: 10.1007/s00464-013-3276-x. Epub 2013 Nov 7.</citation>
    <PMID>24196556</PMID>
  </reference>
  <reference>
    <citation>Vix M, Diana M, Liu KH, D'Urso A, Mutter D, Wu HS, Marescaux J. Evolution of glycolipid profile after sleeve gastrectomy vs. Roux-en-Y gastric bypass: results of a prospective randomized clinical trial. Obes Surg. 2013 May;23(5):613-21. doi: 10.1007/s11695-012-0827-5.</citation>
    <PMID>23207829</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 26, 2015</study_first_submitted>
  <study_first_submitted_qc>June 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 18, 2015</study_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sleeve gastrectomy</keyword>
  <keyword>Roux-en-Y gastric bypass</keyword>
  <keyword>Excess weight loss</keyword>
  <keyword>Quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

